Assessing Immune Dysfunction in Sepsis

Not yet recruitingOBSERVATIONAL
Enrollment

150

Participants

Timeline

Start Date

November 1, 2025

Primary Completion Date

November 1, 2028

Study Completion Date

November 1, 2028

Conditions
Sepsis
Interventions
OTHER

Observational Only

No intervention is included in this study

Trial Locations (1)

55455

University of Minnesota, Minneapolis

All Listed Sponsors
lead

University of Minnesota

OTHER

NCT07154615 - Assessing Immune Dysfunction in Sepsis | Biotech Hunter | Biotech Hunter